Physical measurement of tumor size indicated that mice treated with B7-H3 CAR T cells and B7-H3-CXCR2 CAR T cells had statistically smaller tumors compared to control mice, though tumor rates growth between CAR T cell treatment groups were not statistically different (Fig. 7D). This evidence concerns the gene CXCR2 and neoplasm.